• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫中血红蛋白降解产物的鉴定

Identification of hemoglobin degradation products in Plasmodium falciparum.

作者信息

Kamchonwongpaisan S, Samoff E, Meshnick S R

机构信息

Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor 48109-2029, USA.

出版信息

Mol Biochem Parasitol. 1997 Jun;86(2):179-86. doi: 10.1016/s0166-6851(97)02855-7.

DOI:10.1016/s0166-6851(97)02855-7
PMID:9200124
Abstract

Malaria parasites break down human hemoglobin to its constituent amino acids by cysteine and aspartic proteinases. However, no one has previously been able to identify hemoglobin cleavage products in intact parasites. When isolated parasites were subjected to non-denaturing polyacrylamide gels electrophoresis, a unique protein band was found which contains heme and reacts with anti-human hemoglobin antibodies. This protein does not appear to represent oxidized or glycosylated hemoglobin, and is present in isolated parasites but not in the cytosol of infected or uninfected erythrocytes. When this band was eluted and subjected to SDS polyacrylamide gel electrophoresis, three bands were seen on Western blots. The proteins in these bands contain proteins with the N-terminal sequences of alpha- and beta-globin chains but molecular masses of only 13.2-13.4 kDa. These data suggest that hemoglobin alpha- and beta-chains are initially cleaved within the parasite phagolysosome to release peptides of 15-17 and 23-25 amino acids from the C-termini of alpha- and beta-globin chains, respectively. Production of the hemoglobin breakdown products was inhibited by E-64, a cysteine proteinase inhibitor, suggesting the involvement of a cysteine proteinase in an early step of hemoglobin degradation.

摘要

疟原虫通过半胱氨酸和天冬氨酸蛋白酶将人血红蛋白分解为其组成氨基酸。然而,此前没有人能够在完整的疟原虫中鉴定出血红蛋白裂解产物。当将分离的疟原虫进行非变性聚丙烯酰胺凝胶电泳时,发现了一条独特的蛋白带,该蛋白带含有血红素并能与抗人血红蛋白抗体发生反应。这种蛋白似乎不代表氧化或糖基化的血红蛋白,它存在于分离的疟原虫中,但不存在于感染或未感染红细胞的胞质溶胶中。当洗脱这条带并进行SDS聚丙烯酰胺凝胶电泳时,在Western印迹上可见三条带。这些带中的蛋白质含有具有α-和β-珠蛋白链N端序列的蛋白质,但分子量仅为13.2 - 13.4 kDa。这些数据表明,血红蛋白α链和β链最初在疟原虫吞噬溶酶体内被切割,分别从α链和β链的C端释放出15 - 17个和23 - 25个氨基酸的肽段。半胱氨酸蛋白酶抑制剂E - 64抑制了血红蛋白分解产物的产生,这表明半胱氨酸蛋白酶参与了血红蛋白降解的早期步骤。

相似文献

1
Identification of hemoglobin degradation products in Plasmodium falciparum.恶性疟原虫中血红蛋白降解产物的鉴定
Mol Biochem Parasitol. 1997 Jun;86(2):179-86. doi: 10.1016/s0166-6851(97)02855-7.
2
Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites.半胱氨酸蛋白酶抑制剂可阻断培养的疟原虫降解血红蛋白的早期步骤。
Blood. 1996 May 15;87(10):4448-54.
3
Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites.恶性疟原虫:蛋白酶抑制剂对培养的疟原虫血红蛋白水解作用的影响
Exp Parasitol. 1995 Mar;80(2):272-81. doi: 10.1006/expr.1995.1033.
4
A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.疟原虫半胱氨酸蛋白酶对于恶性疟原虫降解血红蛋白是必需的。
J Clin Invest. 1988 Nov;82(5):1560-6. doi: 10.1172/JCI113766.
5
Purification of human erythrocyte proteolytic enzyme responsible for degradation of oxidant-damaged hemoglobin. Evidence for identifying as a member of the multicatalytic proteinase family.负责降解氧化损伤血红蛋白的人红细胞蛋白水解酶的纯化。鉴定为多催化蛋白酶家族成员的证据。
Biochim Biophys Acta. 1990 Mar 1;1037(3):337-43. doi: 10.1016/0167-4838(90)90035-e.
6
Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.恶性疟原虫血红蛋白降解途径的顺序和特异性。
J Clin Invest. 1994 Apr;93(4):1602-8. doi: 10.1172/JCI117140.
7
Stage-specific antimalarial activity of cysteine protease inhibitors.半胱氨酸蛋白酶抑制剂的阶段特异性抗疟活性。
Biol Chem. 2002 May;383(5):843-7. doi: 10.1515/BC.2002.089.
8
Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation.恶性疟原虫血红蛋白降解相关酶——天然疟原虫蛋白酶的特性分析
Mol Biochem Parasitol. 1996 Dec 20;83(2):189-200. doi: 10.1016/s0166-6851(96)02772-7.
9
The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.恶性疟原虫半胱氨酸蛋白酶疟原虫蛋白酶-2通过一个独特的基序捕获其底物血红蛋白。
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9138-43. doi: 10.1073/pnas.0502368102. Epub 2005 Jun 17.
10
The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion.疟原虫环子孢子蛋白在细胞入侵过程中会经历蛋白水解加工。
J Exp Med. 2005 Jan 3;201(1):27-33. doi: 10.1084/jem.20040989.

引用本文的文献

1
Application of QSAR Method in the Design of Enhanced Antimalarial Derivatives of Azetidine-2-carbonitriles, their Molecular Docking, Drug-likeness, and SwissADME Properties.定量构效关系(QSAR)方法在氮杂环丁烷-2-腈类增强抗疟衍生物设计中的应用、其分子对接、类药性及瑞士ADME性质
Iran J Pharm Res. 2021 Summer;20(3):254-270. doi: 10.22037/ijpr.2021.114536.14901.
2
COULD COVID-19 BE A HEMOGLOBINOPATHY?COVID-19 可能是一种血红蛋白病吗?
Acta Clin Croat. 2020 Dec;59(4):740-744. doi: 10.20471/acc.2020.59.04.21.
3
Theoretical design of novel antimalarial agents against strain, Dd through the QSAR modeling of synthesized 2'-substituted triclosan derivatives.
通过对合成的2'-取代三氯生衍生物进行定量构效关系建模,设计新型抗疟药以对抗Dd菌株的理论研究。
Heliyon. 2020 Sep 28;6(9):e05032. doi: 10.1016/j.heliyon.2020.e05032. eCollection 2020 Sep.
4
Phagocytic uptake of oxidized heme polymer is highly cytotoxic to macrophages.氧化血红素聚合物的吞噬摄取对巨噬细胞具有高度细胞毒性。
PLoS One. 2014 Jul 31;9(7):e103706. doi: 10.1371/journal.pone.0103706. eCollection 2014.
5
A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR.一项使用MEP图谱和多元定量构效关系对抗疟青蒿素衍生物的研究。
J Mol Model. 2008 Jan;14(1):39-48. doi: 10.1007/s00894-007-0249-9. Epub 2007 Oct 30.
6
New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins.新型小分子非肽类化合物通过抑制疟原虫天冬氨酸蛋白酶,在体外阻断恶性疟原虫的发育。
Antimicrob Agents Chemother. 2001 Sep;45(9):2577-84. doi: 10.1128/AAC.45.9.2577-2584.2001.
7
Proteases of malaria parasites: new targets for chemotherapy.疟原虫蛋白酶:化疗的新靶点
Emerg Infect Dis. 1998 Jan-Mar;4(1):49-57. doi: 10.3201/eid0401.980107.